Durability of response to peginterferon alfa-2a (40 KD) (PEGASYS (R)) treatment in Asian patients with HBeAg-negative chronic hepatitis B: 12 month follow-up data from a large randomised study
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY（2006）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要